USA: 
Europe: 
Email: 
Consultation
| Catalog: | C0809T |
| Product Type: | Test kit |
| Unit: | 96 tests |
| Regulatory status: | RUO |
| Incubation time: | 1x1h, 2x30min |
| Standard range: | 1.25 - 80 pmol/L |
| Sample type: | Serum, plasma |
| Sample requirements: | 5 µL serum, EDTA plasma, 50 µL cell culture supernatant |
| Isotope/Substrate: | TMB 450 nm |
| Analysis mode: | ELISA |
| Application: | Metabolic Syndrome |
ANGPTL8 is a lipoprotein regulator that inhibits LPL activity by activating ANGPTL3, and is therefore considered to be a target molecule for improving current hyperlipidemia drugs or a biomarker for metabolic diseases. The kit detects the full length of ANGPTL8 protein in a human sample.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Biogene. All rights reserved.
